OraPharm Inc., the Professional Oral Probiotics Company, Starts Research on Antiviral Effects

[Global Economic Daily] 02.27.2020.

It is not an overstatement to say that we are all in a war against virus. The war against not only bacteria, but also viruses is being continued in modern times. Pandemics occur in cycles. The 4 pandemics we had, the SARS pandemic in 2003, H1N1 pandemic in 2009, outbreak of MERS in 2015, and COVID-19 pandemic in 2020, have shown us that such cycles have been getting shorter and the far-reaching effects of the pandemic have been getting greater. People have tried so hard and continuously to overcome viruses. Unfortunately, further research is still needed. 

To protect yourself and others from viruses, thorough hand washing and good oral hygiene practices are essential since most viruses enter our body through the respiratory system including the mouth and nose. If the proportion of harmful bacteria increases due to poor oral hygiene habits, oral health can’t be kept and the mouth can’t play its role in blocking harmful substances from spreading to other areas of our body. 

OraPharm Inc.(formerly, ORADENTICS Inc.), the company specialized in oral probiotics, said to expand its research associated with oral probiotics and study not only oral conditions such as dental caries, halitosis, and periodontitis that they used to study, but also viruses. 

“OraPharm has already verified the effects of Weissella cibaria CMU, a probiotic strain patented by the company, on immune system and confirmed the potential of Weissella cibaria CMU as an antiviral agent and such. The company is planning to buckle down to prove effects of oral probiotics in stimulating the immune system to combat various viral infections in the mouth,” one of the OraPharm staff said.

OraPharm Inc., meanwhile, is selling ‘Green Breath’ and ‘OraDenti’, probiotic products containing probiotic strains patented by OraPharm. 

Original Source: Global Economic Daily(https://bit.ly/33zuX6f)